AAMA
ABBV icon

Advanced Asset Management Advisors’s AbbVie ABBV Stock Holding History

Advanced Asset Management Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-68
Closed -$11K – 94
2022
Q4 		$11K Buy
+68
New +$10.4K ﹤0.01% 154
2018
Q2 		– Sell
-18,855
Closed -$1.78M – 125
2018
Q1 		$1.78M Hold
18,855
– – 0.59% 38
2017
Q4 		$1.82M Buy
+18,855
New +$1.78M 0.6% 37

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Advanced Asset Management Advisors's ABBV Position: Q1 2023 in Review

Advanced Asset Management Advisors sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 68 shares — an estimated $11K sold.

Advanced Asset Management Advisors first reported a position in ABBV in Q4 2017 and held it in 3 quarters. The position peaked at $1.82M in Q4 2017. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • Advanced Asset Management Advisors reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
  • Advanced Asset Management Advisors sold 68 AbbVie shares in Q1 2023, an estimated $11K.
  • Advanced Asset Management Advisors first reported a position in AbbVie in Q4 2017 and held it in 3 quarters.
  • Advanced Asset Management Advisors's AbbVie position peaked at $1.82M in Q4 2017.
  • 3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Advanced Asset Management Advisors's 13F filing for Q1 2023, filed 11 May 2023.